Delivery Order SPE2DX15D9517-SPE2DX24FFRGW

Award Date 4/16/24
Potential Completion Date 4/17/24
Potential Value $6.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The $1,184.00 firm fixed-price delivery order contract has an ultimate completion date of April 26, 2024 and provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and Department of Veterans Affairs (VA) medical centers nationwide. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $12,934.05. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which provides pharmaceutical and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA). DMS Pharmaceutical Group specializes in supplying a wide range of branded and generic prescription drugs,...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) to support the medical needs of the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $1,573.20 firm fixed-price delivery order, which is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, covers a comprehensive array of items...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division. The $47,176.48 firm fixed-price delivery order has an ultimate completion date of June 26, 2024, and is not designated as a set-aside contract. Through this award, DMS Pharmaceutical Group will provide a wide range of pharmaceutical products and medical supplies, including branded and generic...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical centers nationwide. The $6,807.83 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division and does not have a set-aside designation. DMS Pharmaceutical Group holds a significant...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) for distribution to Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities. The $23,699.64 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which covers a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract, valued at up to $18,526.83, is a firm fixed-price delivery order with no set-aside designation. It covers the supply of various medications, including branded and generic prescription drugs,...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides for the delivery of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities and VA medical centers nationwide. The $1,150.35 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) under a firm fixed-price delivery order contract. The award, valued at $2,443.50, is part of the DLA's Medical Supply Chain program and covers a wide range of pharmaceuticals, including branded and generic prescription drugs, over-the-counter medications, biologics, and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $3,024.30 firm fixed-price delivery order covers the supply of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical needs of military health facilities worldwide....
  • SPE2DX15D9517
    Indefinite Delivery Contract
  • SPE2DX15D9517-SPE2DX24FFRGW
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $6,224.44 firm fixed-price delivery order contract has an ultimate completion date of April 17, 2024.

DMS Pharmaceutical Group provides a wide range of pharmaceutical products and medical supplies to support the recurring needs of military health facilities and Department of Veterans Affairs (VA) medical centers. This includes branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across multiple therapeutic classes.

The contract is not designated as a set-aside. It is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for comprehensive pharmaceutical items to military healthcare facilities worldwide.

Generated 7/16/24, 12:18 PM